Back
Xilio Therapeutics, Inc. 10K Form
Sell
32
XLO
Xilio Therapeutics, Inc.
Last Price:
$0.67
Seasonality Move:
-27.24%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive XLO News And Ratings
See the #1 stock for the next 7 days that we like better than XLO
XLO Financial Statistics
Sales & Book Value
| Annual Sales: | $6.3M |
|---|---|
| Cash Flow: | $-17.5M |
| Price / Cash Flow: | 2.05 |
| Annual Sales: | $-0.16 |
| Price / Book: | 5.19 |
Profitability
| EPS (TTM): | -0.65730 |
|---|---|
| Net Income (TTM): | $-58.5M |
| Gross Margin: | $4.7M |
| Return on Equity: | -606.15% |
| Return on Assets: | -56.57% |
Xilio Therapeutics, Inc. Earnings Forecast
Key Xilio Therapeutics, Inc. Financial Ratios
-
The Gross Profit Margin over the past 4 years for XLO is 74.09%.
-
The Selling, General & Administrative Expenses for XLO have been equal to 390.57% of Gross Profit Margin.
-
The Research & Development expenses have been 649.61% of Revenue.
-
The Net Earning history of XLO is -918.05% of Total Revenues.
-
Per Share Earnings over the last 6 years have been positive in 2 years.
Xilio Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | XLO |
| Website: | xiliotx.com |
Debt
| Debt-to-Equity Ratio: | -0.9 |
|---|---|
| Current Ratio: | 2.2 |
| Quick Ratio: | 2.15 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
XLO Technical Analysis vs Fundamental Analysis
Sell
32
Xilio Therapeutics, Inc. (XLO)
is a Sell
Is Xilio Therapeutics, Inc. a Buy or a Sell?
-
Xilio Therapeutics, Inc. stock is rated a SellThe current Xilio Therapeutics, Inc. [XLO] share price is $0.67. The Score for XLO is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.